Current Diabetes Reports

, Volume 12, Issue 1, pp 88–92 | Cite as

Determining Genetic Risk Factors for Pediatric Type 2 Diabetes

  • Angharad R. MorganEmail author
Pediatric Type 2 Diabetes (M Freemark, Section Editor)


The prevalence of type 2 diabetes (T2D) is increasing significantly in the pediatric population. A strong family history of the disease suggests the involvement of genetic factors for diabetes development, but defining the molecular genetics of T2D in children is difficult due to a low number of subjects and the lack of robust diagnostic criteria. Thus, genetic studies of T2D have been carried out almost exclusively in adults. In this review, the genetics of T2D is summarized and options for discovering the missing heritability explored. The review concludes with a discussion of future research that will be required for determining genetic risk factors for pediatric T2D.


Pediatric type 2 diabetes Genetics Susceptibility genes Missing heritability Genetic risk factors 



No potential conflict of interest relevant to this article was reported.


Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Rosenbloom AL, Young RS, Joe JR, Winter WE. Emerging epidemic of type 2 diabetes in youth. Diabetes Care. 1999;22(2):345–54.PubMedCrossRefGoogle Scholar
  2. 2.
    Cali AM, Caprio S. Prediabetes and type 2 diabetes in youth: an emerging epidemic disease? Curr Opin Endocrinol Diabetes Obes. 2008;15(2):123–7.PubMedCrossRefGoogle Scholar
  3. 3.
    • Wilmot EG, Davies MJ, Yates T, et al. Type 2 diabetes in younger adults: the emerging UK epidemic. Postgrad Med J. 2010;86(1022):711–8. This is an excellent review of pediatric T2D describing the epidemiology of T2D in younger adults, as well as the risk factors involved, clinical presentation, diagnostic difficulties, complications, comorbidities, and management.PubMedCrossRefGoogle Scholar
  4. 4.
    Berry D, Urban A, Grey M. Understanding the development and prevention of type 2 diabetes in youth (part 1). J Pediatr Health Care. 2006;20(1):3–10.PubMedCrossRefGoogle Scholar
  5. 5.
    American Diabetes Association. Type 2 diabetes in children and adolescents. Pediatrics. 2000;105(3):671–80.CrossRefGoogle Scholar
  6. 6.
    •• Barker A, Sharp SJ, Timpson NJ, et al. Association of genetic loci with glucose levels in childhood and adolescence: a meta-analysis of over 6,000 children. Diabetes 2011;60(6):1805–12. This is the first study to demonstrate that the majority of novel fasting glucose loci identified in GWAS of adults are detectable in childhood and with effect sizes comparable to those reported in replication studies of adults. The study overcomes the problem of false-negative replication results by meta-analyzing a total of six studies including more than 6000 children and adolescents, constituting the largest study of fasting glucose-associated loci in children and adolescents to date. PubMedCrossRefGoogle Scholar
  7. 7.
    • Dabelea D, Dolan LM, D’Agostino R Jr, et al. Association testing of TCF7L2 polymorphisms with type 2 diabetes in multi-ethnic youth. Diabetologia 2011;54(3):535–9. This is the first report on TCF7L2 variation in a sample of well-characterized youth with T2D and healthy controls in two racial/ethnic groups. PubMedCrossRefGoogle Scholar
  8. 8.
    Raitakari OT, Ronnemaa T, Huupponen R, et al. Variation of the transcription factor 7-like 2 (TCF7L2) gene predicts impaired fasting glucose in healthy young adults: the Cardiovascular Risk in Young Finns Study. Diab Care. 2007;30:2299–301.CrossRefGoogle Scholar
  9. 9.
    Sladek R, Rocheleau G, Rung J, et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature. 2007;445:881–5.PubMedCrossRefGoogle Scholar
  10. 10.
    Wellcome Trust Case Control Consortium. Genome-wide association Study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447:661–78.CrossRefGoogle Scholar
  11. 11.
    Saxena R, Voight BF, Lyssenko V, et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science. 2007;316:1331–6.PubMedCrossRefGoogle Scholar
  12. 12.
    Scott LJ, Mohlke KL, Bonnycastle LL, et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science. 2007;316:1341–5.PubMedCrossRefGoogle Scholar
  13. 13.
    Steinthorsdottir V, Thorleifsson G, Reynisdottir I, et al. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet. 2007;39(6):770–5.PubMedCrossRefGoogle Scholar
  14. 14.
    Gudmundsson J, Sulem P, Steinthorsdottir V, et al. Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat Genet. 2007;39:977–83.PubMedCrossRefGoogle Scholar
  15. 15.
    Zeggini E, Scott LJ, Saxena R, et al. Metaanalysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet. 2008;40(5):638–45.PubMedCrossRefGoogle Scholar
  16. 16.
    Yasuda K, Miyake K, Horikawa Y, et al. Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat Genet. 2008;40(9):1092–7.PubMedCrossRefGoogle Scholar
  17. 17.
    Unoki H, Takahashi A, Kawaguchi T, et al. SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations. Nat Genet. 2008;40(9):1098–102.PubMedCrossRefGoogle Scholar
  18. 18.
    Rung J, Cauchi S, Albrechtsen A, et al. Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia. Nat Genet. 2009;41(10):1110–5.PubMedCrossRefGoogle Scholar
  19. 19.
    Dupuis J, Langenberg C, Prokopenko I, et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet. 2010;42(2):105–16.PubMedCrossRefGoogle Scholar
  20. 20.
    Voight BF, Scott LJ, Steinthorsdottir V, et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet. 2010;42(7):579–89.PubMedCrossRefGoogle Scholar
  21. 21.
    Qi L, Cornelis MC, Kraft P, et al. Genetic variants at 2q24 are associated with susceptibility to type 2 diabetes. Hum Mol Genet. 2010;19:2706–15.PubMedCrossRefGoogle Scholar
  22. 22.
    Florez JC, Jablonski KA, Bayley N, et al. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med. 2006;355(3):241–50.PubMedCrossRefGoogle Scholar
  23. 23.
    Wang J, Kuusisto J, Vanttinen M, et al. Variants of transcription factor 7-like 2 (TCF7L2) gene predict conversion to type 2 diabetes in the Finnish Diabetes Prevention Study and are associated with impaired glucose regulation and impaired insulin secretion. Diabetologia. 2007;50(6):1192–2000.PubMedCrossRefGoogle Scholar
  24. 24.
    Maher B. The case of the missing heritability. Nature. 2008;456:18–21.PubMedCrossRefGoogle Scholar
  25. 25.
    • Manolio TA, Collins FS, Cox NJ, et al. Finding the missing heritability of complex diseases. Nature 2009;461(7265):747753. This review article examines potential sources of missing heritability and proposes research strategies to illuminate the genetics of complex diseases. Google Scholar
  26. 26.
    Craddock N, Hurles ME, Cardin N, et al. Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature. 2010;464(7289):713–20.PubMedCrossRefGoogle Scholar
  27. 27.
    Meigs JB, Shrader P, Sullivan LM, et al. Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med. 2008;359:2208–19.PubMedCrossRefGoogle Scholar
  28. 28.
    Lango H, UK Type 2 Diabetes Genetics Consortium, et al. Assessing the combined impact of 18 common genetic variants of modest effect sizes on type 2 diabetes risk. Diabetes. 2008;57(11):3129–35.PubMedCrossRefGoogle Scholar
  29. 29.
    Qi Q, Li H, Wu Y, et al. Combined effects of 17 common genetic variants on type 2 diabetes risk in a Han Chinese population. Diabetologia. 2010;53(10):2163–6.PubMedCrossRefGoogle Scholar
  30. 30.
    Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet. 2003;33(Suppl):245–54.PubMedCrossRefGoogle Scholar
  31. 31.
    •• Godfrey KM, Sheppard A, Gluckman PD, et al. Epigenetic gene promoter methylation at birth is associated with child’s later adiposity. Diabetes 2011;60(5):1528–34. This study implicates the human prenatal environment with epigenetic changes in nonimprinted genes and is the first to link epigenetic status at birth with clinically relevant later phenotypic variation such as body composition and metabolic function. PubMedCrossRefGoogle Scholar
  32. 32.
    Grant SF, Thorleifsson G, Reynisdottir I, et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet. 2006;38:320–3.PubMedCrossRefGoogle Scholar
  33. 33.
    Almind K, Bjorbaek C, Vestergaard H, et al. Aminoacid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus. Lancet. 1993;342:828–32.PubMedCrossRefGoogle Scholar
  34. 34.
    Deeb SS, Fajas L, Nemoto M, et al. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet. 1998;20:284–7.PubMedCrossRefGoogle Scholar
  35. 35.
    Hani EH, Boutin P, Durand E, et al. Missense mutations in the pancreatic islet beta cell inwardly rectifying K+ channel gene (KIR6.2/BIR): a meta-analysis suggests a role in the polygenic basis of type II diabetes mellitus in Caucasians. Diabetologia. 1998;41:1511–5.PubMedCrossRefGoogle Scholar
  36. 36.
    Minton JA, Hattersley AT, Owen K, et al. Association studies of genetic variation in the WFS1 gene and type 2 diabetes in U.K. populations. Diabetes. 2002;51:1287–90.PubMedCrossRefGoogle Scholar
  37. 37.
    Sandhu MS, Weedon MN, Fawcett KA, et al. Common variants in WFS1 confer risk of type 2 diabetes. Nat Genet. 2007;39:951–3.PubMedCrossRefGoogle Scholar
  38. 38.
    Winckler W, Burtt NP, Holmkvist J, et al. Association of common variation in the HNF1alpha gene region with risk of type 2 diabetes. Diabetes. 2005;54:2336–42.PubMedCrossRefGoogle Scholar
  39. 39.
    Prokopenko I, Langenberg C, Florez JC, et al. Variants in MTNR1B influence fasting glucose levels. Nat Genet. 2009;41(1):77–81.PubMedCrossRefGoogle Scholar
  40. 40.
    Lyssenko V, Nagorny CL, Erdos MR, et al. Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nat Genet. 2009;41(1):82–8.PubMedCrossRefGoogle Scholar
  41. 41.
    Bouatia-Naji N, Bonnefond A, Cavalcanti-Proença C, et al. A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk. Nat Genet. 2009;41(1):89–94.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Department of Nutrition, Faculty of Medical and Health SciencesUniversity of AucklandAucklandNew Zealand

Personalised recommendations